Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

Inhibitor Therapy ◽

Factor Inhibitor ◽

Observational Cohort ◽

Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis

Journal of Dermatological Treatment ◽

10.3109/09546634.2012.713460 ◽

2012 ◽

Vol 25 (1) ◽

pp. 61-62 ◽

Cited By ~ 1

Author(s):

Amy C. Foulkes ◽

Christopher E. M. Griffiths ◽

Hector Chinoy ◽

Richard B. Warren

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study

10.1136/annrheumdis-2017-eular.4787 ◽

2017 ◽

Author(s):

J Rech ◽

M Hagen ◽

M Englbrecht ◽

J Haschka ◽

M Reiser ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Sustained Remission ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort

Rheumatology ◽

10.1093/rheumatology/kex457 ◽

2017 ◽

Vol 57 (4) ◽

pp. 619-624 ◽

Cited By ~ 9

Author(s):

Fariz Yahya ◽

Karl Gaffney ◽

Louise Hamilton ◽

Ellie Lonsdale ◽

Jane Leeder ◽

...

Keyword(s):

United Kingdom ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Predictors Of Response ◽

Factor Inhibitor ◽

Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical & Experimental Immunology ◽

10.1111/cei.12161 ◽

2013 ◽

Vol 174 (1) ◽

pp. 18-26 ◽

Cited By ~ 23

Author(s):

S. Ceeraz ◽

C. Hall ◽

E. H. Choy ◽

J. Spencer ◽

V. M. Corrigall

Keyword(s):

Rheumatoid Arthritis ◽

T Cell ◽

Tumour Necrosis Factor ◽

Regulatory T Cell ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Suppressor Function ◽

Factor Inhibitor ◽

248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy

Rheumatology ◽

10.1093/rheumatology/kez107.064 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Deepak R Jadon ◽

Mani Haschemi Nassab ◽

Katrien Van Beneden ◽

Georg Pum ◽

Andrew J Bradley

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Inadequate Response ◽

Factor Inhibitor ◽

OP0106 The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2017-eular.1500 ◽

2017 ◽

Author(s):

C Ballegaard ◽

P Højgaard ◽

L Dreyer ◽

R Cordtz ◽

TS Jørgensen ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

The Impact ◽

THU0332 Fatigue remains a dominatng symptom despite tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2018-eular.6780 ◽

2018 ◽

Cited By ~ 1

Author(s):

T.S. Jørgensen ◽

M. Skougaard ◽

C. Ballegaard ◽

P. Mease ◽

V. Strand ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply

Rheumatology Advances in Practice ◽

10.1093/rap/rky037 ◽

2018 ◽

Vol 2 (2) ◽

Author(s):

Fariz Yahya ◽

Karl Gaffney ◽

Louise Hamilton ◽

Ellie Lonsdale ◽

Jane Leeder ◽

...

Keyword(s):

United Kingdom ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Predictors Of Response ◽

Factor Inhibitor ◽

O11 Drug-Specific Risk and Associated Factors with Vasculitis-Like Events in Patients Exposed to Tumour Necrosis Factor Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/kew120.004 ◽

2016 ◽

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Associated Factors ◽

Inhibitor Therapy ◽

British Society ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Biologics Register

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-203407 ◽

2013 ◽

Vol 73 (11) ◽

pp. 1942-1948 ◽

Cited By ~ 64

Author(s):

John W Baddley ◽

Kevin L Winthrop ◽

Lang Chen ◽

Liyan Liu ◽

Carlos G Grijalva ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Safety Assessment ◽

Biologic Therapy ◽

Opportunistic Infections ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽